Simvastatin News
Companies Pull TV Ads for Vytorin
N.J._Merck & Co. and Schering-Plough Corp. said Tuesday they have suspended TV ads for Vytorin, a week after a study revealed the cholesterol drug is no more effective than a high dose of one of its components available...
Astrazeneca Announces First Patient Enrolled In Head-To-Head Comparison Of CRESTOR/Ezetimibe With SIMVASTATIN/Ezetimibe
AstraZeneca announced enrollment of the first patient in the new GRAVITY study (Gauging the lipid effects of RosuvAstatin plus ezetimibe Versus sImvastatin plus ezetimibe TherapY). GRAVITY is a clinical trial examining the impact...
Switch to cheap statins 'raises risk of heart attack or stroke'
Millions of patients being transferred to cheaper generic versions of statin drugs may suffer a greater risk of heart attacks and strokes, a study says.
Ranbaxy's Simvastatin to go Down Under by Aug
Drug major Ranbaxy Laboratories is planning to launch generic version of blockbuster cardiovascular drug Simvastatin in Australia this year.
New Analysis Shows Potential For Lipitor To Significantly Reduce The Risk Of Serious Cardiovascular Events Compared To Simvastatin
A retrospective analysis of a U.S. managed care database of 80,909 patients showed that those who took Pfizer's cholesterol-lowering medicine LipitorŪ (atorvastatin calcium) had a significant 14 percent reduction in the relative...